ENVB

Business Context and Reporting Period

Company: Spatializer Audio Laboratories, Inc. (Note: Metadata listed "Enveric Biosciences" is incorrect; the filing text identifies Spatializer Audio Laboratories, Inc.)
Reporting Period: Quarter and six months ended June 30, 2007.
Business Overview: The Company developed and licensed audio signal processing technologies. Operations were effectively suspended in 2006 while pursuing the sale of substantially all assets to DTS, Inc. The asset sale was approved by stockholders on June 15, 2007, and closed on July 2, 2007. The Company has no future revenue streams from its historical business model and plans to distribute remaining cash to stockholders after a nine-month indemnification period.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Surge: Revenues increased 288% for the quarter and 274% for the six-month period compared to the prior year. This was driven by a licensing extension payment received in Q1 2007, recognized over the remaining asset ownership period prior to the sale. No such revenue is expected in the future.
• Profitability Turnaround: The Company reported a net income of $149,768 for the quarter and $383,426 for the six months, reversing net losses of $62,989 and $236,380, respectively, in the comparable 2006 periods.
• Expense Reduction: Research and Development expenses dropped to zero for the current periods (down from $157,740 in the prior six months) due to the suspension of operations and resignation of engineering staff. Sales and Marketing expenses were also eliminated.
• Liquidity Improvement: Cash and cash equivalents increased by approximately $584,000 during the six months ended June 30, 2007, primarily due to net income and proceeds from a private stock sale in April 2007.

Outlook, Risks, and Management Commentary

• Cessation of Operations: The Company sold substantially all assets to DTS, Inc. on July 2, 2007. There is no source of revenue beginning in the third quarter of 2007.
• Future Plan: Management intends to satisfy liabilities and, after a nine-month indemnification period, distribute remaining cash assets to stockholders, retaining a $100,000 residual. There is no assurance that funds will remain for distribution.
• Management Transition: Upon cash distribution, current directors are expected to resign, and a new investor group (from the April 2007 stock offering) will take control. A new business model or financing may be pursued, likely diluting existing shareholders.
• Going Concern: The financial statements are prepared assuming a going concern, but the Company's circumstances raise substantial doubt about its ability to continue without a new business model and outside funding.
• Internal Controls: The Company disclosed a material weakness in internal controls due to limited segregation of duties, with only one part-time employee and a contract bookkeeper managing financial records.

Investor Verification Checklist

• Asset Sale Closing: Verify the final closing date and terms of the asset sale to DTS, Inc. (Closed July 2, 2007).
• Cash Distribution: Monitor the nine-month indemnification period for any claims that could reduce the cash available for distribution to shareholders.
• Management Change: Confirm the resignation of current directors and the appointment of the new management group following the cash distribution.
• Future Business Plan: Assess any new business proposals or financing plans from the new investor group, noting the high risk of dilution.
• Liabilities: Review the status of the $33,881 note payable and accrued professional fees ($148,974) to ensure they are satisfied prior to any distribution.